產(chǎn)品描述: | Miriplatin (SM-11355) is a chemotherapy agent which belongs to the class of alkylating agents. |
靶點(diǎn): |
DNA Alkylator/Crosslinker;DNAAlkylator/Crosslinker |
體外研究: |
Miriplatin (SM-11355) suspended in LPD (miriplatin/LPD, 100 μg/mL) inhibits the growth of AH109A cells, forms platinum-DNA adducts, and induces apoptosis |
體內(nèi)研究: |
Miriplatin (SM-11355) (0.02-0.4 mg/20 μL) in lipiodol reduces tumor growth rates in a dose dependent manner in rats bearing AH109A tumor cells. Miriplatin/LPD (400 μg/head) significantly reduces the growth of tumor in rats bearing AH109A cells |
參考文獻(xiàn): |
1. Kishimoto S, et al. Antitumor effects of a novel lipophilic platinum complex (SM-11355) against a slowly-growing rat hepatic tumor after intra-hepatic arterial administration. Biol Pharm Bull. 2000 Mar;23(3):344-8. 2. Hanada M, et al. Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of tumors implanted in rat livers by inducing platinum-DNA adducts to form and massive apoptosis. Cancer Chemother Pharmacol. 2009 Aug;64(3):473-83. |
溶解性: |
10 mM in DMSO |
保存條件: |
-20℃ |
配置溶液濃度參考: |
|
1mg |
5mg |
10mg |
1 mM |
1.309 ml |
6.545 ml |
13.089 ml |
5 mM |
0.262 ml |
1.309 ml |
2.618 ml |
10 mM |
0.131 ml |
0.654 ml |
1.309 ml |
50 mM |
0.026 ml |
0.131 ml |
0.262 ml |
|
注意: |
部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。 |